🇺🇸 FDA
Patent

US 6323226

Treatment of heart disease with cox-2 inhibitors

expired A61KA61K31/00A61K31/138

Quick answer

US patent 6323226 (Treatment of heart disease with cox-2 inhibitors) held by The Board of Regents of the University of Texas System expires Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/00, A61K31/138, A61K31/34, A61K31/365